Medicines Marketed by Galpha Laboratories Limited

About Galpha Laboratories Limited

Galpha Laboratories Limited, a prominent player in the pharmaceutical sector, has been manufacturing and marketing high-quality pharmaceutical formulations (Finished Dosage Forms) since its establishment in 1984. With its registered office in Patna, Bihar, and manufacturing facilities in Ankleshwar, Gujarat, and Solan, Himachal Pradesh, the company has made significant strides in the industry.

Galpha Laboratories Limited has strategically expanded its business and strengthened its manufacturing capabilities to cater to a wide range of international customers in both regulated and emerging pharmaceutical markets. The company's global presence is a testament to its commitment to quality and its ability to serve diverse healthcare needs worldwide.

Galpha Laboratories Limited Products

Galpha Laboratories Limited offers a comprehensive range of pharmaceutical formulations across various therapeutic segments, including anti-inflammatory products, antibiotics, multi-vitamins, analgesics, and gynaecological formulations. The company's portfolio comprises more than 30 brands with diverse formulations, reducing its dependence on any single segment and ensuring a well-balanced product mix.

Some of the popular products are Algyfree 5 mg Syrup, Galoff 200 mg Tablet, Diclogal 1% Gel, Galpara Drops, Ezivac Isabgol Husk Powder, Dompital 10mg Suspension, Cdcef-S 1.5gm Injection, Keenmind Capsule, and Beepraz-D Capsule SR.

The company's products are manufactured in state-of-the-art facilities that adhere to the highest standards of quality and comply with international regulatory requirements, such as EU GMP approval for its Baddi Plant. This commitment to quality and compliance enhances the credibility and trust of Galpha Laboratories Limited among its customers and regulatory bodies.

The company's extensive experience in the pharmaceutical industry, spanning over four decades, enables it to understand local market dynamics and cater to the diverse healthcare needs of its global consumer base. With its strong financial performance, including increased revenues and healthy operating margins, Galpha Laboratories Limited is well-positioned for continued growth and success in the pharmaceutical industry.